Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Oncology Institute of Southern Switzerland clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Switzerland and Italy registers with Oncology Institute of Southern Switzerland as lead sponsor. Synced 17 Nov 2026
10Current trials
9Recruiting now
1Drug in these trials
2Trial registers
At a glance

Oncology Institute of Southern Switzerland is the lead sponsor of 10 current clinical trials in our Switzerland and Italy registers. 9 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Metronidazole. The most-studied condition is Prostate Cancer.

ClinicalTrials.gov trials by status

  • Recruiting990%
  • Active, closed110%

Trials by phase

  • Observational770%
  • Not applicable220%
  • Phase 2110%
01

Clinical trials sponsored by Oncology Institute of Southern Switzerland

10 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
NCT05748145 · ClinicalTrials.gov ↗ · Colorectal Cancer
Phase 2 Recruiting 2023-09 Switzerland
Tumor Molecular Profiling in Early Phase Clinical Trials
NCT04510766 · ClinicalTrials.gov ↗ · Advanced Solid Tumor, Lymphoma
Observational Recruiting 2020-10 Switzerland
LUCINAE Registry: Thoracic Cancers During Pregnancy
NCT07699861 · ClinicalTrials.gov ↗ · Lung Cancer, Thoracic Cancer, Cancer During Pregnancy
Observational Recruiting 2026-04 Switzerland
Lifestyle Intervention in Patients With Metastatic Prostate Cancer
NCT05850182 · ClinicalTrials.gov ↗ · Prostate Cancer
Not applicable Recruiting 2023-11 Switzerland
The Immune Landscape of Epithelial Ovarian Cancer
NCT05984875 · ClinicalTrials.gov ↗ · Epithelial Ovarian Cancer
Observational Recruiting 2022-12 Switzerland
Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer
NCT04543799 · ClinicalTrials.gov ↗ · Prostate Cancer, Breast Cancer
Observational Recruiting 2020-09 Switzerland
Effect of a Music Intervention in Reducing Distress and Pain in Patients With Lung Cancer Undergoing Mini-invasive Surgery
NCT07235098 · ClinicalTrials.gov ↗ · Lung Cancer (Suspected or Confirmed)
Not applicable Recruiting 2026-06 Switzerland
Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients
NCT03408964 · ClinicalTrials.gov ↗ · Prostate Cancer
Observational Recruiting 2017-12 Switzerland
Liquid Biopsy in Mature B-cell Tumors
NCT03280394 · ClinicalTrials.gov ↗ · Mature B-Cell Neoplasm
Observational Recruiting 2017-09 Switzerland
Personalized Risk Stratification Model of Follicular Lymphoma Patients
NCT03436602 · ClinicalTrials.gov ↗ · Follicular Lymphoma
Observational Active, closed 2018-03 Italy, Switzerland

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in Oncology Institute of Southern Switzerland trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in Oncology Institute of Southern Switzerland trials

12 conditions
Prostate Cancer3Follicular Lymphoma1Colorectal Cancer1Advanced Solid Tumor1Lymphoma1Lung Cancer1Thoracic Cancer1Cancer During Pregnancy1Epithelial Ovarian Cancer1Breast Cancer1Lung Cancer (Suspected or Confirmed)1Mature B-Cell Neoplasm1
06

Questions about Oncology Institute of Southern Switzerland trials

How many clinical trials does Oncology Institute of Southern Switzerland sponsor?

Oncology Institute of Southern Switzerland is the lead sponsor of 10 current trials on ClinicalTrials.gov in our Switzerland and Italy registers, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are Oncology Institute of Southern Switzerland trials recruiting?

Yes. 9 of its 10 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Oncology Institute of Southern Switzerland testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Metronidazole (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.